IHL - INCANNEX - HOLDERS RESEARCH, page-235

What we know

Concerning the NASDAQ Listing,
IHL has passed the SEC scrutiny stages and is now awaiting the most opportunistic date for Share Holders to list on the NASDAQ.
@Rhino 78 - "Had a good chat to Joel this morning and he was happy for me to say they have met SEC requirements and are ready to roll. They just are not listing in the winpaeek before Xmas because it’s silly. They are all systems go for Jan."

"now look forward to marketing the Offering and listing on Nasdaq in January when institutional investors are back on deck after the relatively short winter holiday period in the northern hemisphere" https://stocknessmonster.com/announcements/ihl.asx-3A584039/

Concerning the Development Pipelines, Refresh our memories - Last News Items
- 20th OCT - ......." is pleased to announce that it has engaged Procaps S.A. (‘Procaps’) to develop and
manufacture IHL-42X soft gel capsules, the Company’s proprietary combination cannabinoid drug under development for the treatment of obstructive sleep apnoea (‘OSA’) The soft gel capsules will be pharmaceutical-grade and used in pivotal phase 2, phase 3, and open-label clinical
trials. Procaps is also equipped to provide subsequent commercial manufacture at scale."
https://stocknessmonster.com/announcements/ihl.asx-3A578612/
-28th OCT - ......." is pleased to announce: 1. that the Phase 2a Psi-GAD clinical trial, led by Dr Paul Liknaitzky at Monash University, has received
approval to proceed from the Monash University Human Research Ethics Committee (MUHREC); and 2. the completion of its pre-Investigational New Drug Application (‘pre-IND’) meeting with the US Food and Drug Administration (‘FDA’) regarding the Company’s clinical development program comprising psilocybin-assisted psychotherapy for Generalised Anxiety Disorder (‘GAD’)
https://stocknessmonster.com/announcements/ihl.asx-3A579437/



These timelines can be very dynamic, so we can anticipate there may be some variations in this table.
I am anticipating some news Q1.2022

> Results for Sleep Apnoea (IHL-42X) and or an Announcement surrounding the progress of the Trials and what is planned for 2022 in regard to the next phases of trials. Also possible news on a Pre-Ind Meeting request.
> Results for IHL-216A (TBI) Stage 2 Pre-Clinical Trials and or an Announcement surrounding the progress and possible news on a Pre-Ind Meeting request.
> Commencement of PSI-GAD enrollments from 10th January 2022 per my previous post on this.... https://hotcopper.com.au/threads/general-discussion.5330178/page-10740?post_id=58320947

-------------------------------------------------------------------------

The big question for me now is when will the news feed for our development pipeline re-commence?
The issue is we are in between our SEC approval and the issue of our Effectiveness Notice and the commencement of trading on the NASDAQ.
The Notice of Effect date will be selected by Joel but how will he determine this date with the following requirement in his mind.....

Provide timely disclosure of material information
A public company should disclose all material information (unless there is a legitimate reason for not doing so), both favorable and unfavorable, as promptly as possible. Information that is generally considered material includes significant financial transactions, new products or services, acquisitions or dispositions of assets, dividend changes and top management or control changes. The disclosure of such information should be made as soon as (1) it is reasonably accurate, and (2) full details are available to the company. This information is usually disseminated by press releases; however, companies may decide to also send announcements directly to their shareholders. Generally, the need to disclose information should be discussed with legal counsel.
https://www.pwc.com/hu/hu/szolgaltatasok/konyvvizsgalat/szamviteli-tanacsadas/kiadvanyok/roadmap_for_an_ipo.pdf

My assumption here is that Joel could perhaps issue some news prior to the IHXL Listing on the NASDAQ in January, but that may be unlikely because the Form F1/A would need to be re-issued with the updates pertaining to that new news. On the other hand, we did see some news released in between Filings dated 28th September and 3rd November. Those news dates were on 20th, 28th & 29th October.

We did see a rise in our SP as a result of those news releases which had the effect of reducing the number of shares that needed to be issued.

"in conjunction with its investment bank Roth Capital Partners, believes that is has adequately addressed such comments, and is in a position to conduct the Offering in January 2022.Incannex has ample existing placement capacity under ASX Listing Rules 7.1 and 7.1A to complete the Offering, particularly following a rise in share price over the preceding 3 months."
https://stocknessmonster.com/announcements/ihl.asx-3A584039/

I for one thought the BOD took advantage of the delays with SEC and subsequent rise in the Share Price and savings.

This strategy could be, maybe, we'll see be continued between now and the "EFFECTIVE DATE" Another boost to the share price would result in fewer ADS required.

More likely IMO we'll see a listing date sometime in the first week or second week of the New Year, once all the intos are back on deck and we can get the best IPO exposure followed up by some announcement shortly afterward unless the MATERIAL News is more pressing as far as the regulations are concerned and prevails and precede the listing date.

Good luck all holders!
Have a lovely Christmas - LUV YAS ALL !